Breaking Finance News

Sensient Technologies Corporation (NYSE:SXT) has been downgraded to Hold in a statement by Zacks Investment Research earlier today.

Zacks Investment Research has downgraded Sensient Technologies Corporation (NYSE:SXT) to Hold in a statement released on Friday June 16, 2017.

On 6/8/2017, Zacks Investment Research released a statement on Sensient Technologies Corporation (NYSE:SXT) bumped up the target price from $0.00 to $91.00 that suggested an upside of 0.12%.

Boasting a price of $81.79, Sensient Technologies Corporation (NYSE:SXT) traded 1.19% higher on the day. With the last close up -2.25% from the two hundred day average, compared with the S&P 500 Index which has increased 0.04% over the date range. Sensient Technologies Corporation has recorded a 50-day average of $73.46 and a two hundred day average of $78.57. Volume of trade was down over the average, with 129,373 shares of SXT changing hands under the typical 170,783

Performance Chart

Sensient Technologies Corporation (NYSE:SXT)

With a total market value of $0, Sensient Technologies Corporation has price-earnings ratio of 30.93 with a one year low of $68.51 and a one year high of $84.98 .

More About Sensient Technologies Corporation (NYSE:SXT)

Sensient Technologies Corporation is a manufacturer and marketer of colors, flavors and fragrances. The Company uses technologies at facilities around the world to develop specialty food and beverage systems, cosmetic and pharmaceutical systems, specialty inks and colors, and other specialty and fine chemicals. The Company's three segments include the Flavors & Fragrances Group and the Color Group, which are managed on a product-and-services basis, and the Asia Pacific Group, which is managed on a geographic basis. The Company's principal products include flavors, flavor enhancers and bionutrients; fragrances, aroma chemicals and essential oils; natural ingredients, including dehydrated vegetables and other food ingredients; natural and synthetic food and beverage colors; cosmetic colors and ingredients and pharmaceutical excipients and ingredients, and technical colors, specialty inks and colors, and specialty dyes and pigments.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.